Clinical Trial Update: Study of Neoadjuvant Treatment of Locally Advanced Breast Cancer With CAP Regimen [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial evaluating the CAP regimen (cyclophosphamide, doxorubicin, paclitaxel) for locally advanced breast cancer, including triple-negative…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• Taxol (paclitaxel)

Snippet

Sponsor: Instituto Nacional de Cancer, Brazil | Conditions: Triple Negative Breast Cancer Patients | Phase 2 | Status: COMPLETED